Capricor Therapeutics, Inc.
CAPR
$29.96
$23.60371.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.57M | -25.91M | -24.39M | -7.12M | -12.56M |
| Total Depreciation and Amortization | 494.70K | 486.30K | 405.50K | 375.70K | 361.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.38M | 3.63M | 5.87M | 2.39M | 2.04M |
| Change in Net Operating Assets | 5.70K | 1.67M | 11.68M | -10.45M | -1.49M |
| Cash from Operations | -19.69M | -20.12M | -6.43M | -14.80M | -11.64M |
| Capital Expenditure | -4.01M | -1.45M | -1.14M | -734.70K | -59.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.96M | 16.00M | 25.03M | -122.65M | 2.06M |
| Cash from Investing | 15.95M | 14.55M | 23.89M | -123.38M | 2.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.00K | 19.60K | 50.40K | 81.09M | 67.33M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.00K | 19.60K | 50.40K | 81.09M | 67.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.73M | -5.55M | 17.51M | -57.09M | 57.69M |